This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Early Registration Savings Deadline Expires In

  • 00
    DAYS
  • 00
    HRS
  • 00
    MINS
  • 00
    SECS
Delivered as a Hybrid Event from September 20-30, 2021
Live In-Person Experience Delivered September 20-23Boston Convention and Exhibition Center

Sarah Nikiforow
Asst. Professor, Stem Cell Transplantation Program, Asst. Medical Director, Cell Manipulation Core Facility at Dana-Farber Cancer Institute

Profile

Dr. Nikiforow is currently an Assistant Professor at Harvard Medical School with the Stem Cell Transplant Program at Dana-Farber Cancer Institute, Medical Director of the Cell Manipulation Core Facility (CMCF), and Technical Director of DFCI’s Immune Effector Cell Program.  Dr. Nikiforow earned her MD and a PhD in Immunobiology at Yale University working on the differential roles of CD4 and CD8 T cells in immune control over Epstein-Barr virus-induced B-cell transformation.

Dr. Nikiforow has pursued a translational research career focusing on immune reconstitution after stem cell transplant and therapeutic use of adoptive cellular products.  Through the CMCF and as Principal Investigator of Phase I and II clinical trials, she is working to bring cellular therapies such as chimeric antigen-receptor T cells, genetically-modified stem cells, and regulatory T-cell infusions into the clinic at Dana-Farber.  Her work with the International Society of Cellular Therapy, the Foundation for the Accreditation of Cellular Therapy and the Center for International Blood & Marrow Transplant Research have promoted education and set standards for safe implementation of new approaches within the broader and ever-growing cellular therapy field.

Agenda Sessions

  • Panel: Patient Case Management & Developing Patient journey methods for Cell & Gene Therapies

    4:15pm

Speakers at this event